Acambis Plc ADR 20-F Annual Report June 2005

1073965 Annual Reports

20-F Annual Report June 2006

20-F Annual Report June 2005
Select PDF Feature:

Include Exhibits

Highlight YoY Changes

20-F Only

20-F Annual Report June 2004

Acambis Plc

HISTORY TOOLS

CIK: 1073965

Please wait while we load the requested 20-F report or click the link below:

https://last10k.com/sec-filings/report/1073965/000115697305001067/u49003e20vf.htm

View differences made from one year to another to evaluate Acambis Plc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ) — *Sample 10-K Year-over-Year (YoY) Comparison*

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were ~~removed~~ , added and changed by Acambis Plc.

Continue

Assess how Acambis Plc's management team is paid from their Annual Proxy

Acambis Plc's Definitive Proxy Statement (Form DEF 14A) filed after their 2005 10-K Annual Report includes:

Voting Procedures
Board Members
Executive Team
Salaries, Bonuses, Perks
Peers / Competitors

Continue

Material Contracts, Statements, Certifications & more

Acambis Plc provided additional information to their SEC Filing as exhibits

Exhibit 1.2: Underwriting Agreement

Exhibit 4.9: Instruments Defining The Rights Of Security Holders, Including Indentures

Exhibit 4.51: Instruments Defining The Rights Of Security Holders, Including Indentures

Exhibit 4.52: Instruments Defining The Rights Of Security Holders, Including Indentures

Exhibit 4.53: Instruments Defining The Rights Of Security Holders, Including Indentures

Exhibit 4.54: Instruments Defining The Rights Of Security Holders, Including Indentures

Exhibit 8.1: Opinion Regarding Tax Matters

Exhibit 12.1: Statement Regarding Calculation Of Ratios

Exhibit 12.2: Statement Regarding Calculation Of Ratios

Exhibit 13.1: Report To Security Holders

Exhibit 13.2: Report To Security Holders

Exhibit 15.1: Letter Regards Unaudited Interim Financial Information

CIK: 1073965
Form Type: 20-F Annual Report
Accession Number: 0001156973-05-001067
Submitted to the SEC: Thu Jun 30 2005 10:02:12 AM EST
Accepted by the SEC: Thu Jun 30 2005
Period: Friday, December 31, 2004
Industry: Pharmaceutical Preparations